See more : HEXO Corp. (HEXO) Income Statement Analysis – Financial Results
Complete financial analysis of DENTSPLY SIRONA Inc. (XRAY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DENTSPLY SIRONA Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- G.S. Auto International Limited (GSAUTO.BO) Income Statement Analysis – Financial Results
- BayWa Aktiengesellschaft (BYW6.DE) Income Statement Analysis – Financial Results
- Ashley Services Group Limited (ASH.AX) Income Statement Analysis – Financial Results
- Beibu Gulf Port Co., Ltd. (000582.SZ) Income Statement Analysis – Financial Results
- Sanshin Electronics Co., Ltd. (8150.T) Income Statement Analysis – Financial Results
DENTSPLY SIRONA Inc. (XRAY)
About DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.97B | 3.92B | 4.25B | 3.34B | 4.03B | 3.99B | 3.99B | 3.75B | 2.67B | 2.92B | 2.95B | 2.93B | 2.54B | 2.22B | 2.16B | 2.19B | 2.01B | 1.81B | 1.72B | 1.69B | 1.57B | 1.51B | 1.13B | 889.80M | 830.90M | 795.10M | 720.80M | 656.60M | 572.00M | 524.80M | 552.60M | 84.60M | 54.50M | 29.40M | 18.60M | 16.20M | 12.70M | 10.30M |
| Cost of Revenue | 1.88B | 1.80B | 1.89B | 1.69B | 1.86B | 1.92B | 1.80B | 1.74B | 1.16B | 1.32B | 1.37B | 1.37B | 1.26B | 1.09B | 1.05B | 1.04B | 969.05M | 881.49M | 846.12M | 847.71M | 797.72M | 780.84M | 559.42M | 384.84M | 359.30M | 341.20M | 319.60M | 303.80M | 269.70M | 247.00M | 274.00M | 52.30M | 33.70M | 18.00M | 11.50M | 9.90M | 8.00M | 7.00M |
| Gross Profit | 2.09B | 2.13B | 2.36B | 1.66B | 2.17B | 2.07B | 2.19B | 2.00B | 1.52B | 1.60B | 1.58B | 1.56B | 1.27B | 1.13B | 1.11B | 1.15B | 1.04B | 929.01M | 869.02M | 846.52M | 773.20M | 732.90M | 569.67M | 504.95M | 471.60M | 453.90M | 401.20M | 352.80M | 302.30M | 277.80M | 278.60M | 32.30M | 20.80M | 11.40M | 7.10M | 6.30M | 4.70M | 3.30M |
| Gross Profit Ratio | 52.61% | 54.23% | 55.54% | 49.58% | 53.74% | 51.87% | 54.80% | 53.42% | 56.73% | 54.74% | 53.46% | 53.15% | 50.18% | 50.88% | 51.45% | 52.51% | 51.78% | 51.31% | 50.67% | 49.96% | 49.22% | 48.42% | 50.45% | 56.75% | 56.76% | 57.09% | 55.66% | 53.73% | 52.85% | 52.93% | 50.42% | 38.18% | 38.17% | 38.78% | 38.17% | 38.89% | 37.01% | 32.04% |
| Research & Development | 184.00M | 174.00M | 171.00M | 115.00M | 131.30M | 160.50M | 151.70M | 128.50M | 74.90M | 80.80M | 85.10M | 85.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.62B | 1.60B | 1.55B | 0.00 | 0.00 | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 675.37M | 606.41M | 563.34M | 544.26M | 501.52M | 479.13M | 386.24M | 299.73M | 282.40M | 275.10M | 236.30M | 205.20M | 180.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | -7.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.62B | 1.59B | 1.55B | 1.44B | 1.72B | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 675.37M | 606.41M | 563.34M | 544.26M | 501.52M | 479.13M | 386.24M | 299.73M | 282.40M | 275.10M | 236.30M | 205.20M | 180.10M | 160.30M | 180.00M | 16.70M | 10.50M | 5.50M | 3.90M | 3.40M | 2.90M | 2.30M |
| Other Expenses | 374.00M | 1.29B | 18.00M | 271.00M | 115.00M | 1.34B | 2.07B | 44.10M | 81.20M | 11.10M | 13.40M | -490.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.43M | 0.00 | 0.00 | 0.00 | 0.00 | 5.07M | 41.36M | 39.60M | 37.50M | 32.40M | 28.10M | 21.50M | 20.00M | 19.80M | 4.20M | 3.00M | 2.40M | 1.20M | 500.00K | 500.00K | 400.00K |
| Operating Expenses | 2.18B | 1.76B | 1.72B | 1.44B | 1.72B | 1.72B | 1.67B | 1.52B | 1.08B | 1.14B | 1.14B | 1.15B | 936.85M | 738.90M | 723.23M | 739.17M | 680.54M | 602.98M | 563.34M | 544.26M | 501.52M | 479.13M | 391.31M | 341.09M | 322.00M | 312.60M | 268.70M | 233.30M | 201.60M | 180.30M | 199.80M | 19.70M | 12.90M | 6.70M | 4.40M | 3.90M | 3.30M | 2.70M |
| Cost & Expenses | 4.05B | 3.56B | 3.61B | 3.12B | 3.59B | 3.64B | 3.48B | 3.27B | 2.23B | 2.47B | 2.52B | 2.52B | 2.20B | 1.83B | 1.77B | 1.78B | 1.65B | 1.48B | 1.41B | 1.39B | 1.30B | 1.26B | 950.73M | 725.94M | 681.30M | 653.80M | 588.30M | 537.10M | 471.30M | 427.30M | 473.80M | 72.00M | 46.60M | 24.70M | 15.90M | 13.80M | 11.30M | 9.70M |
| Interest Income | 0.00 | 60.00M | 55.00M | 1.00M | 2.40M | 2.10M | 2.40M | 2.00M | 2.20M | 5.59M | 8.12M | 8.76M | 9.46M | 4.25M | 5.03M | 17.09M | 26.43M | 12.48M | 9.01M | 5.47M | 1.87M | 0.00 | 0.00 | 862.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 81.00M | 60.00M | 55.00M | 48.00M | 29.40M | 37.30M | 38.30M | 35.90M | 55.90M | 46.91M | 49.63M | 56.85M | 44.62M | 25.09M | 17.83M | 32.53M | 11.98M | 10.80M | 17.77M | 25.10M | 26.08M | 38.18M | 0.00 | 10.15M | 8.50M | 157.10M | 8.10M | 6.00M | 12.20M | 0.00 | 39.20M | 3.80M | 2.80M | 800.00K | 0.00 | 200.00K | 400.00K | 400.00K |
| Depreciation & Amortization | 343.00M | 328.00M | 346.00M | 334.00M | 322.80M | 330.80M | 316.40M | 271.70M | 122.90M | 129.08M | 127.90M | 129.20M | 85.04M | 66.34M | 65.18M | 56.93M | 50.29M | 47.43M | 50.56M | 49.30M | 45.66M | 43.86M | 54.33M | 41.36M | 39.60M | 37.50M | 32.40M | 28.10M | 21.50M | 20.00M | 19.80M | 3.00M | 2.40M | 1.20M | 500.00K | 500.00K | 400.00K | 400.00K |
| EBITDA | 232.00M | -677.00M | 972.00M | 336.00M | 706.60M | -585.30M | -1.25B | 770.50M | 579.30M | 575.25M | 544.88M | 513.34M | 378.71M | 440.00M | 437.28M | 444.33M | 432.26M | 373.21M | 139.00M | 348.77M | 317.34M | 297.63M | 232.70M | 205.22M | 189.20M | 178.70M | 164.90M | 147.60M | 122.20M | 117.50M | 98.60M | 31.60M | 15.60M | 10.30M | 5.90M | 3.20M | 2.90M | 1.80M |
| EBITDA Ratio | 5.85% | 16.17% | 23.57% | 23.64% | 20.97% | 49.83% | 65.43% | 20.63% | 18.87% | 16.01% | 15.11% | 14.80% | 13.26% | 18.11% | 17.97% | 22.19% | 20.92% | 21.14% | 33.94% | 21.25% | 19.96% | 20.02% | 18.64% | 23.38% | 22.41% | 31.40% | 22.56% | 22.08% | 21.64% | 21.95% | 18.24% | 18.79% | 18.72% | 20.07% | 16.67% | 17.90% | 14.17% | 9.71% |
| Operating Income | -85.00M | 306.00M | 622.00M | 456.00M | 522.30M | -958.10M | -1.59B | 454.70M | 375.20M | 445.60M | 419.17M | 381.94M | 300.73M | 380.27M | 381.19M | 380.42M | 354.89M | 314.79M | 72.92M | 295.13M | 267.98M | 256.50M | 178.36M | 163.86M | 149.60M | 141.30M | 132.50M | 119.50M | 100.70M | 97.50M | 78.80M | 12.60M | 7.90M | 4.70M | 2.70M | 2.40M | 1.40M | 600.00K |
| Operating Income Ratio | -2.14% | 7.80% | 14.63% | 13.64% | 12.96% | -24.03% | -39.70% | 12.14% | 14.03% | 15.25% | 14.21% | 13.04% | 11.85% | 17.12% | 17.65% | 17.34% | 17.66% | 17.39% | 4.25% | 17.42% | 17.06% | 16.94% | 15.80% | 18.42% | 18.00% | 17.77% | 18.38% | 18.20% | 17.60% | 18.58% | 14.26% | 14.89% | 14.50% | 15.99% | 14.52% | 14.81% | 11.02% | 5.83% |
| Total Other Income/Expenses | -90.00M | -118.00M | -63.00M | -57.00M | -7.60M | -400.00K | -41.20M | -13.80M | -45.50M | -41.23M | -49.87M | -51.26M | -44.62M | -22.62M | -17.83M | -24.95M | 3.24M | 43.00K | -234.64M | -20.98M | -16.79M | -35.52M | 6.76M | -12.06M | -11.50M | -86.10M | -10.40M | -8.60M | -10.60M | -5.90M | -23.00M | -2.30M | -3.50M | -2.90M | -800.00K | 300.00K | -200.00K | -300.00K |
| Income Before Tax | -175.00M | -1.06B | 559.00M | -60.00M | 345.40M | -958.40M | -1.63B | 440.90M | 329.70M | 404.37M | 369.34M | 330.68M | 256.11M | 357.66M | 363.36M | 355.47M | 358.14M | 314.84M | 71.04M | 274.16M | 251.20M | 220.99M | 185.13M | 151.80M | 138.10M | 55.10M | 122.10M | 110.90M | 90.10M | 91.60M | 55.80M | 9.10M | 5.00M | 3.90M | 2.70M | 2.20M | 1.10M | 0.00 |
| Income Before Tax Ratio | -4.41% | -26.90% | 13.15% | -1.80% | 8.57% | -24.04% | -40.73% | 11.77% | 12.33% | 13.84% | 12.52% | 11.29% | 10.09% | 16.10% | 16.82% | 16.20% | 17.82% | 17.39% | 4.14% | 16.18% | 15.99% | 14.60% | 16.40% | 17.06% | 16.62% | 6.93% | 16.94% | 16.89% | 15.75% | 17.45% | 10.10% | 10.76% | 9.17% | 13.27% | 14.52% | 13.58% | 8.66% | 0.00% |
| Income Tax Expense | -43.00M | -105.00M | 138.00M | 23.00M | 82.30M | 52.50M | -53.20M | 9.50M | 77.00M | 81.12M | 52.15M | 8.92M | -11.02M | 89.23M | 88.94M | 71.60M | 98.48M | 91.12M | 25.63M | 63.87M | 81.34M | 73.03M | 63.63M | 50.78M | 48.20M | 20.30M | 47.50M | 43.70M | 36.10M | 37.50M | 27.70M | 3.80M | 2.10M | 1.50M | 1.00M | 900.00K | 300.00K | 500.00K |
| Net Income | -132.00M | -950.00M | 411.00M | -83.00M | 262.90M | -1.01B | -1.57B | 429.90M | 251.20M | 322.85M | 313.19M | 314.21M | 244.52M | 265.71M | 274.26M | 283.87M | 259.65M | 223.72M | 45.41M | 253.17M | 174.18M | 147.95M | 121.50M | 101.02M | 89.90M | 34.80M | 74.60M | 67.20M | 54.00M | 62.00M | 14.10M | 5.30M | 2.90M | 2.40M | 1.70M | 1.30M | 800.00K | 100.00K |
| Net Income Ratio | -3.33% | -24.22% | 9.67% | -2.48% | 6.52% | -25.36% | -39.39% | 11.48% | 9.39% | 11.05% | 10.61% | 10.73% | 9.64% | 11.96% | 12.70% | 12.94% | 12.92% | 12.36% | 2.65% | 14.94% | 11.09% | 9.77% | 10.76% | 11.35% | 10.82% | 4.38% | 10.35% | 10.23% | 9.44% | 11.81% | 2.55% | 6.26% | 5.32% | 8.16% | 9.14% | 8.02% | 6.30% | 0.97% |
| EPS | -0.62 | -4.41 | 1.88 | -0.38 | 1.18 | -4.51 | -6.86 | 1.97 | 1.79 | 2.28 | 2.20 | 2.22 | 1.73 | 1.85 | 1.85 | 1.90 | 1.71 | 1.44 | 0.29 | 1.58 | 1.11 | 0.95 | 0.78 | 0.65 | 0.57 | 0.22 | 0.46 | 0.42 | 0.33 | 0.37 | 0.09 | 0.10 | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.00 |
| EPS Diluted | -0.62 | -4.41 | 1.87 | -0.38 | 1.17 | -4.51 | -6.86 | 1.94 | 1.76 | 2.24 | 2.16 | 2.18 | 1.70 | 1.82 | 1.83 | 1.87 | 1.68 | 1.41 | 0.28 | 1.55 | 1.09 | 0.93 | 0.77 | 0.65 | 0.56 | 0.22 | 0.46 | 0.42 | 0.33 | 0.37 | 0.09 | 0.10 | 0.07 | 0.07 | 0.05 | 0.04 | 0.02 | 0.00 |
| Weighted Avg Shares Out | 212.00M | 215.50M | 218.40M | 219.20M | 223.10M | 224.17M | 229.29M | 218.00M | 140.00M | 141.70M | 142.70M | 141.85M | 141.39M | 143.98M | 148.32M | 149.07M | 151.71M | 155.23M | 159.19M | 160.77M | 157.65M | 156.36M | 155.34M | 155.57M | 158.26M | 159.99M | 161.81M | 161.52M | 162.07M | 165.99M | 151.00M | 52.97M | 43.48M | 34.27M | 33.98M | 29.99M | 34.27M | 29.99M |
| Weighted Avg Shares Out (Dil) | 212.00M | 215.50M | 220.20M | 219.20M | 224.40M | 224.30M | 229.40M | 221.60M | 142.50M | 144.20M | 145.00M | 143.95M | 143.55M | 145.99M | 150.10M | 151.68M | 154.72M | 158.27M | 162.02M | 164.03M | 161.29M | 159.99M | 157.95M | 157.12M | 158.73M | 160.79M | 162.69M | 161.52M | 162.19M | 165.99M | 156.59M | 52.97M | 43.48M | 34.27M | 33.98M | 29.99M | 34.27M | 29.99M |
January 27, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against XRAY
NEW YORK, NY / ACCESSWIRE / December 6, 2024 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Investors in Dentsply Sirona Inc. Should Contact Levi & Korsinsky Before January 27, 2025 to Discuss Your Rights - XRAY
NEW YORK, NY / ACCESSWIRE / December 6, 2024 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Investors who Lost Money on Dentsply Sirona Inc. (XRAY) Should Contact Levi & Korsinsky About Pending Class Action - XRAY
NEW YORK, NY / ACCESSWIRE / December 6, 2024 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
The Schall Law Firm Invites Investor Participation In A Fraud Case Against DENTSPLY SIRONA Inc.
LOS ANGELES, CA / ACCESSWIRE / December 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for violations of 10(b)...
Contact Levi & Korsinsky by January 27, 2025 Deadline to Join Class Action Against Dentsply Sirona Inc. (XRAY)
NEW YORK, NY / ACCESSWIRE / December 6, 2024 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
XRAY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Dentsply Sirona Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / December 6, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY)...
Levi & Korsinsky Reminds Dentsply Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025 - XRAY
NEW YORK , Dec. 6, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Dentsply...
Levi & Korsinsky Notifies Dentsply Sirona Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – XRAY
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XRAY
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between...
Dentsply Sirona Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before January 27, 2025 to Discuss Your Rights – XRAY
NEW YORK, NY / ACCESSWIRE / December 5, 2024 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Source: https://incomestatements.info
Category: Stock Reports